Form D · Biotechnology
CyVek, Inc.
Wallingford, CT · CIK 0001483965
Offering snapshot reported Apr 7, 2014 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 2, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2014 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Jan 13, 2014 | Initial | $1,854,410 | No comparison | 16 | SEC filing |
| Feb 7, 2013 | Initial | $5,499,999 | No comparison | 19 | SEC filing |
| Apr 12, 2012 | Initial | $2,999,999 | No comparison | 22 | SEC filing |
| Feb 16, 2010 | Initial | $1,950,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-215023
Source: Form D, filed Apr 7, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| F. Kevin Didden | Director, Executive |
| F Kevin Didden | Director, Executive |
| Per Hellsund | Director, Executive |
| Enrique Posner | Director |
| Kevin Rakin | Director |
| David Wurzer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Barnes Industrial Road South
Wallingford, CT, 06492
Wallingford, CT, 06492